Survival analysis in patients with CRC from The Cancer Genome Atlas database indicated that elevated transcriptional levels of both MAF and MAFB were linked to poor prognosis in patients with CRC, verifying our findings (Figure 6H). This evidence concerns the gene MAFB and colorectal carcinoma.